1. Home
  2. BLND vs OLMA Comparison

BLND vs OLMA Comparison

Compare BLND & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$3.37

Market Cap

894.7M

Sector

Technology

ML Signal

HOLD

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$26.67

Market Cap

725.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLND
OLMA
Founded
2012
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
894.7M
725.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
BLND
OLMA
Price
$3.37
$26.67
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$4.80
$30.00
AVG Volume (30 Days)
4.3M
8.0M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$167,532,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.61
N/A
52 Week Low
$2.50
$2.86
52 Week High
$5.41
$29.51

Technical Indicators

Market Signals
Indicator
BLND
OLMA
Relative Strength Index (RSI) 58.36 74.04
Support Level $3.10 $25.94
Resistance Level $3.23 $28.82
Average True Range (ATR) 0.15 2.54
MACD 0.04 0.12
Stochastic Oscillator 92.98 72.10

Price Performance

Historical Comparison
BLND
OLMA

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: